Invited Reviews

Secondary Pituitary Hyperplasia: The Long-Term Consequences of Untreated Primary Hormonal Deficiencies

Volume 29 · Issue 4 Publish Date: October 6, 2025
Full Text PDF
DOI
Valentina Gasco ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Daniela Cuboni ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Nunzia Prencipe ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Alessandro Maria Berton ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Fabio Bioletto ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Ezio Ghigo
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Silvia Grottoli ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Gasco, V., Cuboni, D., Prencipe, N., Berton, A. M., Bioletto, F., Ghigo, E., & Grottoli, S. (2025). Secondary Pituitary Hyperplasia: The Long-Term Consequences of Untreated Primary Hormonal Deficiencies. Endocrinology Research and Practice, 29(4), 346–355. https://doi.org/10.5152/erp.2025.25682
Full Text FULL TEXT PDF

Abstract

Pituitary hyperplasia is an enlargement of the pituitary gland resulting from increased cell number. In contrast to adenomas, which are nodular and monoclonal, hyperplasia is a polyclonal process that may manifest in diffuse, focal, or nodular forms, arising in both physiological and pathological con texts. Physiological forms occur during adolescence, pregnancy, and lactation. Pathological hyperpla sia most often results from long-standing primary endocrine gland failure—such as hypothyroidism, adrenal insufficiency, or hypogonadism—although it remains underrecognized. In these cases, chronic loss of negative feedback leads to persistent hypothalamic stimulation, excessive release of thyrotropin-releasing hormone,corticotropin-releasing hormone, and gonadotropin-releasing hor mone, and proliferation of the corresponding pituitary cell populations. Clinically, pituitary hyper plasia may be asymptomatic and detected incidentally, or present with mass effects (headache, bitemporal hemianopia) and/or endocrine dysfunction, including varying degrees of hypopituita rism. Magnetic resonance imaging typically shows diffuse, symmetric adenohypophyseal enlarge ment, sometimes with a dome-shaped superior convexity, but without the focal nodular lesions of adenomas. Combined assessment of pituitary and target gland hormones is essential to establish the underlying cause. Timely recognition is critical for differential diagnosis with other sellar masses and to avoid unnecessary, potentially harmful surgery. Treatment is primarily medical, targeting the endo crine deficiency, and usually leads to stabilization or regression of pituitary enlargement. Surgery is rarely indicated and should be reserved for exceptional cases with persistent or severe mass effect. This review summarizes current evidence on pituitary hyperplasia secondary to primary endocrine insufficiency, emphasizing its pathophysiology, clinical presentation, and diagnostic challenges to promote accurate recognition and appropriate management.

 

Cite this article as: Gasco V, Cuboni D, Prencipe N, et al. Secondary pituitary hyperplasia: the long-term consequences of untreated primary hormonal deficiencies. Endocrinol Res Pract. 2025;29(4):346-355.

Article Info
Published In
Journal Endocrinology Research and Practice
Volume / Issue Volume 29 · Issue 4
Pages 346-355
History
Published Online October 6, 2025
Copyright
Affiliations
Valentina Gasco ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Daniela Cuboni ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Nunzia Prencipe ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Alessandro Maria Berton ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Fabio Bioletto ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Ezio Ghigo
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Silvia Grottoli ORCID
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Cite this Article
Gasco, V., Cuboni, D., Prencipe, N., Berton, A. M., Bioletto, F., Ghigo, E., & Grottoli, S. (2025). Secondary Pituitary Hyperplasia: The Long-Term Consequences of Untreated Primary Hormonal Deficiencies. Endocrinology Research and Practice, 29(4), 346–355. https://doi.org/10.5152/erp.2025.25682
Outlines